共 100 条
[1]
Reaven G.M., Role of insulin resistance in human disease, Diabetes, 37, (1988)
[2]
Kaplan N.M., The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridema, and hypertension, Arch Intern Med, 149, (1989)
[3]
Foster D.W., Insulin resistance — a secret killer?, N Engl J Med, 320, (1989)
[4]
Landin K., Tengborn L., Smith U., Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease, J Intern Med, 227, (1990)
[5]
Barakat H.A., Carpenter J.W., McLendon V.D., Et al., Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition, Diabetes, 39, (1990)
[6]
Reaven G.M., Chen Y-D, Jeppesen J., Et al., Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles, J Clin Invest, 92, (1993)
[7]
DeFronzo R.A., Ferrannini E., Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease, Diabetes Care, 14, (1991)
[8]
Rupp H., Insulin resistance, hyperinsulinemia, and cardiovascular disease: the need for novel dietary prevention strategies, Basic Res Cardiol, 87, pp. 99-105, (1992)
[9]
Ferrannini E., Haffner S.M., Mitchell B.D., Et al., Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome, Diabetiologia, 34, (1991)
[10]
Srinivasan S.R., Bao W., Berenson G.S., Coexistance of increased levels of adiposity, insulin, and blood pressure in a young adult cohort with elevated very-low-density lipoprotein cholesterol: the Bogalusa Heart Study, Metabolism, 42, (1993)